Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.44 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | G6PD | P11413 | 1/20 | 0.44 |
| ▸ | CYP24A1 | Q07973 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | VDR | P11473 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8484861 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL3545668 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL8483813 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4812770 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL11050599 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4951882 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4954181 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL890725 | 0.98 | ALDH1A1 (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL483847 | 0.94 | ALDH1A1 (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4193998 | 0.93 | RECQL (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115785144-B | Thiazole orange organosilicon quaternary ammonium salt compound, and preparation method and application thereof | 苏州百灵威超精细材料有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-115724890-B | Thiazole orange organosilicon quaternary ammonium quaternary phosphonium salt compound, and preparation method and application thereof | 苏州百灵威超精细材料有限公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024185588-A1 | POLYETHER RESIN, METHOD FOR PRODUCING SAME, AND USE OF SAME | 大阪ガスケミカル株式会社 | 2024-09-12 | — | — | WO | disclosed |
| CN-117321115-A | Polyether resin, process for producing the same, and use thereof | 大阪燃气化学有限公司 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023243651-A1 | POLYETHER-BASED RESIN, METHOD FOR PRODUCING SAME, AND APPLICATION THEREOF | 大阪ガスケミカル株式会社 | 2023-12-21 | — | — | WO | disclosed |
| CN-115785144-A | Thiazole orange organosilicon quaternary ammonium salt compound and preparation method and application thereof | 苏州百灵威超精细材料有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115724890-A | Thiazole orange organosilicon quaternary ammonium phosphonium salt compound and preparation method and application thereof | 苏州百灵威超精细材料有限公司 | 2023-03-03 | — | — | CN | disclosed |
| WO-2022244451-A1 | POLYETHER-BASED RESIN, AND PRODUCTION METHOD AND APPLICATION THEREFOR | 大阪ガスケミカル株式会社 | 2022-11-24 | — | — | WO | disclosed |
| US-9240614-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2016-01-19 | — | — | US | disclosed |
| EP-2579377-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES (JP) | 2014-09-03 | — | — | EP | disclosed |
| US-7411096-B2 | Process for producing optically active phosphorus heterocyclic dimer | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2008-08-12 | — | — | US | disclosed |
| US-20060211888-A1 | 2,2'-bis-(1-alkylphosphetanes); a primary alkyl or cycloalkyl phosphine is reacted with 1,3-dichloropropane, in the presence of n-butyllithium, and then reacted with boron trihydride, oxygen, or sulfur, dimerizing, removing the boron trihydride, oxygen, or sulfur; assymetric hydrogenation catalysts | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1650216-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE DIMER OF PHOSPHORUS HETEROCYCLE | NIPPON CHEMICAL INDUSTRIAL COMPANY LIMITED (JP) | 2006-04-26 | — | — | EP | disclosed |
| EP-1086063-A4 | NOVEL POTASSIUM CHANNEL DRUGS AND THEIR USES | ADVANCED MEDICINE INC (US) | 2001-03-28 | — | — | EP | disclosed |
| EP-1086063-A1 | NOVEL POTASSIUM CHANNEL DRUGS AND THEIR USES | Advanced Medicine, Inc. (US) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999064050-A9 | NOVEL POTASSIUM CHANNEL DRUGS AND THEIR USES | ADVANCED MEDICINE INC (US) | 2000-04-20 | — | — | WO | disclosed |
| WO-1999064050-A1 | NOVEL POTASSIUM CHANNEL DRUGS AND THEIR USES | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| EP-0608132-B1 | Coating varnish composition and antifouling coating composition | HITACHI CHEMICAL CO LTD (JP) | 1998-05-20 | — | — | EP | disclosed |
| US-5439511-A | Composition containing polymer obtained by polymerizing unsaturated acid anhydride and another unsaturated compound, specified additive | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1995-08-08 | — | — | US | disclosed |
| EP-0608132-A1 | Coating varnish composition and antifouling coating composition | HITACHI CHEMICAL CO., LTD. (JP) | 1994-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211888-A1 | 2,2'-bis-(1-alkylphosphetanes); a primary alkyl or cycloalkyl phosphine is reacted with 1,3-dichloropropane, in the presence of n-butyllithium, and then reacted with boron trihydride, oxygen, or sulfur, dimerizing, removing the boron trihydride, oxygen, or sulfur; assymetric hydrogenation catalysts | OSBP2, OXSR1, OCIAD2 | ALDH1A1 3674/4885CYP3A4 3353/4885CYP2C9 3111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.